neonatal gastrointestinal perforation, necrotizing enterocolitis, congenital intestinal atresia, eso necrotizing enterocolitis
Conditions
Interventions
During pediatric gastrointestinal surgery, 0.1-0.2 mg/kg of ICG is injected to determine the extent of intestinal resection. If the blood flow is normal, ICG distribution in the intestinal tract is ob
C492448
Sponsors
Takeda Masahiro
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Patients who require pediatric gastrointestinal surgery at the time of consent (neonatal gastrointestinal perforation, necrotizing enterocolitis, congenital intestinal atresia, esophageal atresia, Hirschsprung's disease, anal fistula, etc.) (2) Subjects who have received a thorough explanation of their participation in this study, and who have obtained the free and voluntary written consent of the research subject's surrogate after full understanding of the subject's condition.
Exclusion criteria
Exclusion criteria: (1) Those who could not give their consent to participate in the research (2) Other persons deemed inappropriate as research subjects by the principal investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The postoperative complications (anastomotic suture failure, anastomotic stenosis, and colostomy problems) will be evaluated and observed as evaluation items in the postoperative follow-up. Observation methods will be the same as those used in general medical care, and the frequency of examination will not be increased as a result of participation in this study. | — |
Contacts
Public ContactMasahiro Takeda
Juntendo University School of Medicine
Outcome results
None listed